• BT12 6BA

    United Kingdom

Organisation profile

Organisation profile

The Wellcome-Wolfson Institute for Experimental Medicine is committed to research excellence and is further enhancing the reputation of Queen’s University and Northern Ireland as a hub of innovation.

 

The Institute brings together world-class researchers, experts in the fields of immunology, microbiology, molecular and cell biology and clinical trials. Their collective focus is to understand why patients develop diseases and to make the discoveries which will lead to new therapies and improvements in their quality of life.

 

In particular, our research concentrates on the eye and circulatory system, inflammatory diseases of the lung and microbial (bacterial/viral) infections.

 

Collaboration is critical. We believe that our key strength is our approach to research – scientists and health professionals from different fields working together to tackle global health challenges from new perspectives. The Wellcome-Wolfson building has been designed to allow that to happen.

 

At the heart of everything we do is the goal of finding meaningful treatment for patients, making it work and having a local and global impact.

Fingerprint Dive into the research topics where Wellcome-Wolfson Institute for Experimental Medicine is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.

Macular Degeneration Medicine & Life Sciences
Glaucoma Medicine & Life Sciences
Retina Medicine & Life Sciences
Diabetic Retinopathy Medicine & Life Sciences
Blood Vessels Medicine & Life Sciences
Endothelial Cells Medicine & Life Sciences
Cystic Fibrosis Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1981 2019

2-hydroxylation of Acinetobacter baumannii lipid A contributes to virulence

Bartholomew, T. L., Kidd, T. J., Sá Pessoa, J., Conde Álvarez, R. & Bengoechea, J. A., 25 Mar 2019, In : Infection and Immunity.

Research output: Contribution to journalArticle

Open Access
File
Acinetobacter baumannii
Lipid A
Hydroxylation
Virulence
Interleukin-10

A Core Outcome Set for Critical Care Ventilation Trials

Blackwood, B., Ringrow, S., Clarke, M., Marshall, J. C., Connolly, B., Rose, L. & McAuley, D. F., 25 Jul 2019, In : Critical Care Medicine.

Research output: Contribution to journalArticle

Open Access
File
Delphi Technique
Ventilation
Clinical Trials
Critical Care
Artificial Respiration

Alginate/Chitosan Particle-Based Drug Delivery Systems for Pulmonary Applications

Hill, M., Twigg, M., Sheridan, E. A., Hardy, J. G., Elborn, J. S., Taggart, C. C., Scott, C. J. & Migaud, M. E., 02 Aug 2019, In : Pharmaceutics. 11, 8, 12 p., 379.

Research output: Contribution to journalArticle

Open Access
File
Tobramycin
Chitosan
Mucus
Drug Delivery Systems
Cystic Fibrosis

Prizes

Victoria
Blood Vessels

2008 DR JD WILLIAMSON PRIZE for Best Post-Graduate Medical Research

Reinhold Medina (Recipient), 24 Nov 2008

Prize: Prize (including medals and awards)

School Dentistry
Publications
Biomedical Research
Medicine
chronic illness
research project

Activities 1995 2025

Invited lectures at the 13th International AMD and Retina Congress, Dublin, Ireland

Noemi Lois (Speaker)
31 Oct 2025

Activity: Talk or presentation typesInvited talk

Stem Cells, Cell Therapies and Bioengineering in Lung Biology and Lung Diseases

Anna Krasnodembskaya (Organiser)
15 Jul 201918 Jul 2019

Activity: Participating in or organising an event typesParticipation in conference

University of Aberdeen

Miguel A. Valvano (Invited speaker)
07 Feb 2019

Activity: Talk or presentation typesInvited talk

Press / Media

Queen's University researchers make pneumonia breakthrough

Clifford Taggart

15/06/2018

3 media contributions

Press/Media: Research

MATRIX NI Successful Women in Science

Fionnuala Lundy

23/05/2018

1 media contribution

Press/Media: Public Engagement Activities